KD Logo

The Attractiveness of Investing In Haemonetics Corp. (HAE) is Growing

In a filing, Haemonetics Corp. revealed its President, Global Hospital Strong Stewart W unloaded Company’s shares for reported $0.39 million on Jul 26 ’24. In the deal valued at $91.15 per share,4,312 shares were sold. As a result of this transaction, Strong Stewart W now holds 18,196 shares worth roughly $1.38 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Strong Stewart W bought 4,312 shares, generating $393,039 in total proceeds.

Before that, Lingamneni Anila sold 2,136 shares. Haemonetics Corp. shares valued at $192,240 were divested by the EVP, Chief Technology Officer at a price of $90.00 per share. As a result of the transaction, Lingamneni Anila now holds 21,410 shares, worth roughly $1.63 million.

CL King initiated its Haemonetics Corp. [HAE] rating to a Buy in a research note published on September 13, 2024; the price target was $116. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in mid September with a ‘”a Neutral”‘ rating. BTIG Research began covering HAE with “Buy” recommendation on September 10, 2024. Needham revised its rating on June 12, 2024. It rated HAE as “a Buy” which previously was an “a Hold”.

Price Performance Review of HAE

On Friday, Haemonetics Corp. [NYSE:HAE] saw its stock jump 3.86% to $76.09. Over the last five days, the stock has gained 3.89%. Haemonetics Corp. shares have fallen nearly -11.02% since the year began. Nevertheless, the stocks have fallen -15.09% over the past one year. While a 52-week high of $97.97 was reached on 05/15/24, a 52-week low of $70.74 was recorded on 02/14/24. SMA at 50 days reached $81.56, while 200 days put it at $83.10.

Levels Of Support And Resistance For HAE Stock

The 24-hour chart illustrates a support level at 74.73, which if violated will result in even more drops to 73.36. On the upside, there is a resistance level at 76.99. A further resistance level may holdings at 77.88. The Relative Strength Index (RSI) on the 14-day chart is 48.18, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.75, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 17.87%. Stochastics %K at 47.26% indicates the stock is a holding.

How much short interest is there in Haemonetics Corp.?

A steep rise in short interest was recorded in Haemonetics Corp. stocks on 2024-08-30, growing by 1.29 million shares to a total of 6.09 million shares. Yahoo Finance data shows the prior-month short interest on 2024-07-31 was 4.8 million shares. There was a rise of 21.23%, which implies that there is a positive sentiment for the stock.

The most recent change occurred on October 13, 2022 when Mizuho began covering the stock and recommended ‘”a Buy”‘ rating along with a $90 price target.

Most Popular